Attached files

file filename
EX-31.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE - Clubhouse Media Group, Inc.exhibit_31-2.htm
EX-32.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO U.S.C. SECTION 1350 - Clubhouse Media Group, Inc.exhibit_32-2.htm
EX-32.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO U.S.C. SECTION 1350 - Clubhouse Media Group, Inc.exhibit_32-1.htm
EX-31.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE - Clubhouse Media Group, Inc.exhibit_31-1.htm
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
(Mark One)
 
FORM 10-K/A
(Amendment No. 1)
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2016
 
or
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _____________to ______________
 
Commission file number: 333-140645
 
 
TONGJI HEALTHCARE GROUP, INC.

(Exact name of registrant as specified in its charter)
 
Nevada
99-0364697
State or other jurisdiction of
Incorporation or organization
(I.R.S. Employer
Identification No.)
 
No. 5 Beiji Road
Nanning, Guangxi, People’s Republic of China

(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code 011-86-771-2020000
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Name of each exchange on which registered
 
 
 
 
Securities registered pursuant to Section 12(g) of the Act:
 
Common Stock, $0.001 par value per share

 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No
 
Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
 
 
1
 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
 
Smaller reporting company
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No
 
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter.
 
The aggregate market value of the voting and non-voting common stock of the issuer held by non-affiliates as of June 30, 2016 was approximately $398,179.81 (5,688,283 shares of common stock held by non-affiliates) based upon a closing price of the common stock of $0.07, the price at which the common equity was last sold on June 8, 2016.
 
Note.—If a determination as to whether a particular person or entity is an affiliate cannot be made without involving unreasonable effort and expense, the aggregate market value of the common stock held by non-affiliates may be calculated on the basis of assumptions reasonable under the circumstances, provided that the assumptions are set forth in this Form.
 
APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
 
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes No
 
(APPLICABLE ONLY TO CORPORATE REGISTRANTS)
 
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.
 
As of April 17, 2017, there are 15,812,191 shares of common stock, par value $0.001 issued and outstanding.
 
DOCUMENTS INCORPORATED BY REFERENCE
 
List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980).
 
 
 
 
 
 
 
 
 
 
2
 
 
 
EXPLANATORY NOTE
 
Tongji Healthcare Group Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (the “Form 10-K/A”) to amend its annual report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 Form 10-K”) as originally filed with the Securities and Exchange Commission (the “SEC”) on April 18, 2017 as it had inadvertently excluded information about its principal accounting fees and services for fiscal year 2016. Accordingly, Item 14 of the 2016 Form 10-K is deleted in its entirety and replaced with the following new Item 14.
 
Other than as expressly set forth above, this Form 10-K/A does not, and does not purport to, revise, update, amend or restate the information presented in any Item of the 2016 Form 10-K or reflect any events that have occurred after the filing of the 2016 Form 10-K.
 
 
PART II
 
Item 14.      Principal Accounting Fees and Services.
 
We were billed by our current independent public accounting firms Anton & Chia, LLP, for the following professional services they performed for us during the years ended December 31, 2016 and 2015 as set forth in the table below.
 
 
 
Year Ended December 31,
 
 
 
2016
 
 
2015
 
Audit fees
 $41,000 
 $38,700 
Audit-related fees
 $21,738 
 $16,500 
Tax fees
 $- 
 $- 
All other fees
 $62,738 
 $55,200 
 
Our Board of Directors pre-approves all audit and non-audit services performed by the Company's auditor and the fees to be paid in connection with such services.
 
 
PART IV
 
Item 15.        Exhibits, Financial Statements Schedules
 
The following information required under this item (other than Exhibits 31.1, 31.2, 32.1 and 32.2) were filed as part of the 2016 Form 10-K:
 
(a)
(1) Consolidated Financial Statements.
 
(2) Financial Statement Schedules.
 
(3) Exhibits are incorporated herein by reference or are filed with this report as indicated below.
 
(b)
 
Number
 
Exhibit
 
 
 
2
 
Plan of Merger (Incorporated by reference to the exhibit filed with our registration statement on Form SB-2)
 
 
 
3.1
 
Articles of Incorporation (Incorporated by reference to the exhibit filed with our registration statement on Form SB-2 )
 
 
 
3.2
 
Bylaws (Incorporated by reference to the exhibit filed with our registration statement on Form SB-2)
 
 
 
10.1
 
Employment Agreement, dated March 3, 2011 between the Company and Eric Zhang (Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed on March 9, 2011)
 
 
 
10.2
 
Guangxi Medical Insurance and Designated Medical Institution Agreement (Incorporated by reference to the same exhibit filed with our quarterly report on Form 10-Q filed on May 15, 2014)
 
 
 
10.3
 
Employment Agreement, dated May 2, 2014 between the Company and Eric Zhang (Incorporated by reference to the same exhibit filed with our quarterly report on Form 10-Q filed on May 15, 2014)
 
 
 
10.4
 
Employment Agreement, dated July 30, 2014 between the Company and Eric Zhang (Incorporated by reference to the same exhibit filed with our quarterly report on Form 10-Q filed on August 4, 2014)
 
 
 
21.1
 
List of Subsidiaries
 
 
 
3
 
 
 
101.INS
 
XBRL Instance Document
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase
 
*Filed herewith.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
 
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
Tongji Healthcare Group, Inc.
 
 
 
Date: May 5, 2017
By:
/s/ Yunhui Yu
 
Yunhui Yu
President and Chief Executive Officer
(Principal Executive Officer)
 
 
 
Date: May 5, 2017
By:
/s/ Eric Zhang
 
Eric Zhang
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
 
Signature
 
Title
 
Date
 
 
 
 
 
/s/ Yunhui Yu
 
President, Chief Executive Officer
 
 May 5, 2017
Yunhui Yu
 
and Chairman (Principal Executive Officer)
 
 
 
 
 
 
 
/s/ Eric Zhang
 
Chief Financial Officer
 
May 5, 2017
Eric Zhang
 
(Principal Financial and Accounting Officer)
 
 
 
 
 
 
 
/s/ Xiangwei Zeng
 
Vice President and a Director
 
May 5, 2017
Xiangwei Zeng
 
 
 
 
 
 
 
 
 
/s/ Jialin Zhang
 
Vice President and a Director
 
May 5, 2017
Jialin Zhang
 
 
 
 
 
 
 
 
 
 
5